APO Research, Inc.

APO RESEARCH · REPORT

Nociceptin Receptor

Selected research

Industry Growth & Trends

Global Nociceptin Receptor Industry Growth and Trends Forecast to 2032

Market perspective

The global Nociceptin Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nociceptin Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nociceptin Receptor include Serodus ASA, Orexigen Therapeutics Inc, Grunenthal GmbH, Fuso Pharmaceutical Industries Ltd and Blackthorn Therapeutics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nociceptin Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nociceptin Receptor market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nociceptin Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nociceptin Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nociceptin Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nociceptin Receptor Market by Company

Serodus ASA

Orexigen Therapeutics Inc

Grunenthal GmbH

Fuso Pharmaceutical Industries Ltd

Blackthorn Therapeutics Inc

Nociceptin Receptor Segment by Type

GRTTA-2210

GRT-6010

Cebranopadol

BTRX-246040

AT-403

Others

Nociceptin Receptor Segment by Application

Major Depressive Disorder

Drug Addiction

Diabetic Neuropathic Pain

Postherpetic Neuralgia

Others

Nociceptin Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nociceptin Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nociceptin Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nociceptin Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nociceptin Receptor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nociceptin Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GRTTA-2210 Table 2. Major Company of GRT-6010 Table 3. Major Company of Cebranopadol Table 4. Major Company of BTRX-246040 Table 5. Major Company of AT-403 Table 6. Major Company of Others Table 7. Global Nociceptin Receptor Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 9. Global Nociceptin Receptor Sales Market Share in Volume by Type (2021-2026) Table 10. Global Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 11. Global Nociceptin Receptor Sales Market Share in Value by Type (2021-2026) Table 12. Global Nociceptin Receptor Price by Type (2021-2026) & (US$/unit) Table 13. Global Nociceptin Receptor Sales by Type (2027-2032) & (k units) Table 14. Global Nociceptin Receptor Sales Market Share in Volume by Type (2027-2032) Table 15. Global Nociceptin Receptor Sales by Type (2027-2032) & (US$ Million) Table 16. Global Nociceptin Receptor Sales Market Share in Value by Type (2027-2032) Table 17. Global Nociceptin Receptor Price by Type (2027-2032) & (US$/unit) Table 18. North America Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 19. North America Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 21. Europe Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 25. Latin America Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Nociceptin Receptor Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Nociceptin Receptor Sales by Type (2021-2026) & (US$ Million) Table 28. Nociceptin Receptor Industry Trends Table 29. Nociceptin Receptor Industry Drivers Table 30. Nociceptin Receptor Industry Opportunities and Challenges Table 31. Nociceptin Receptor Industry Restraints Table 32. Global Nociceptin Receptor Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Nociceptin Receptor Revenue Market Share by Company (2021-2026) Table 34. Global Nociceptin Receptor Sales by Company (2021-2026) & (k units) Table 35. Global Nociceptin Receptor Sales Share by Company (2021-2026) Table 36. Global Nociceptin Receptor Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Nociceptin Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Nociceptin Receptor Major Company Production Sites and Headquarters Table 39. Global Nociceptin Receptor Company, Product Type & Application Table 40. Global Nociceptin Receptor Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Nociceptin Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Nociceptin Receptor Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Nociceptin Receptor Sales by Region (2021-2026) & (k units) Table 45. Global Nociceptin Receptor Sales Market Share in Volume by Region (2021-2026) Table 46. Global Nociceptin Receptor Sales by Region (2021-2026) & (US$ Million) Table 47. Global Nociceptin Receptor Sales Market Share in Value by Region (2021-2026) Table 48. Global Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Nociceptin Receptor Sales by Region (2027-2032) & (k units) Table 50. Global Nociceptin Receptor Sales Market Share in Volume by Region (2027-2032) Table 51. Global Nociceptin Receptor Sales by Region (2027-2032) & (US$ Million) Table 52. Global Nociceptin Receptor Sales Market Share in Value by Region (2027-2032) Table 53. Global Nociceptin Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Nociceptin Receptor Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 56. Global Nociceptin Receptor Sales Market Share in Volume by Application (2021-2026) Table 57. Global Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 58. Global Nociceptin Receptor Sales Market Share in Value by Application (2021-2026) Table 59. Global Nociceptin Receptor Price by Application (2021-2026) & (US$/unit) Table 60. Global Nociceptin Receptor Sales by Application (2027-2032) & (k units) Table 61. Global Nociceptin Receptor Sales Market Share in Volume by Application (2027-2032) Table 62. Global Nociceptin Receptor Sales by Application (2027-2032) & (US$ Million) Table 63. Global Nociceptin Receptor Sales Market Share in Value by Application (2027-2032) Table 64. Global Nociceptin Receptor Price by Application (2027-2032) & (US$/unit) Table 65. North America Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 66. North America Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 68. Europe Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 72. Latin America Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Nociceptin Receptor Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Nociceptin Receptor Sales by Application (2021-2026) & (US$ Million) Table 75. Serodus ASA Company Information Table 76. Serodus ASA Business Overview Table 77. Serodus ASA Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Serodus ASA Nociceptin Receptor Product Portfolio Table 79. Serodus ASA Recent Development Table 80. Orexigen Therapeutics Inc Company Information Table 81. Orexigen Therapeutics Inc Business Overview Table 82. Orexigen Therapeutics Inc Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio Table 84. Orexigen Therapeutics Inc Recent Development Table 85. Grunenthal GmbH Company Information Table 86. Grunenthal GmbH Business Overview Table 87. Grunenthal GmbH Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Grunenthal GmbH Nociceptin Receptor Product Portfolio Table 89. Grunenthal GmbH Recent Development Table 90. Fuso Pharmaceutical Industries Ltd Company Information Table 91. Fuso Pharmaceutical Industries Ltd Business Overview Table 92. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio Table 94. Fuso Pharmaceutical Industries Ltd Recent Development Table 95. Blackthorn Therapeutics Inc Company Information Table 96. Blackthorn Therapeutics Inc Business Overview Table 97. Blackthorn Therapeutics Inc Nociceptin Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio Table 99. Blackthorn Therapeutics Inc Recent Development Table 100. North America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 101. North America Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 102. North America Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 103. North America Nociceptin Receptor Sales Forecast by Country (2027-2032) & (k units) Table 104. North America Nociceptin Receptor Sales Market Share Forecast by Country (2027-2032) Table 105. North America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 106. North America Nociceptin Receptor Market Size by Country (2021-2026) & (US$ Million) Table 107. North America Nociceptin Receptor Market Share by Country (2021-2026) Table 108. North America Nociceptin Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 109. North America Nociceptin Receptor Market Share Forecast by Country (2027-2032) Table 110. Europe Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 111. Europe Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 112. Europe Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 113. Europe Nociceptin Receptor Sales Forecast by Country (2027-2032) & (k units) Table 114. Europe Nociceptin Receptor Sales Market Share Forecast by Country (2027-2032) Table 115. Europe Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. Europe Nociceptin Receptor Market Size by Country (2021-2026) & (US$ Million) Table 117. Europe Nociceptin Receptor Market Share by Country (2021-2026) Table 118. Europe Nociceptin Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. Europe Nociceptin Receptor Market Share Forecast by Country (2027-2032) Table 120. Asia-Pacific Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 121. Asia-Pacific Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 122. Asia-Pacific Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 123. Asia-Pacific Nociceptin Receptor Sales Forecast by Country (2027-2032) & (k units) Table 124. Asia-Pacific Nociceptin Receptor Sales Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Nociceptin Receptor Market Size by Country (2021-2026) & (US$ Million) Table 127. Asia-Pacific Nociceptin Receptor Market Share by Country (2021-2026) Table 128. Asia-Pacific Nociceptin Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Asia-Pacific Nociceptin Receptor Market Share Forecast by Country (2027-2032) Table 130. Latin America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 131. Latin America Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 132. Latin America Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 133. Latin America Nociceptin Receptor Sales Forecast by Country (2027-2032) & (k units) Table 134. Latin America Nociceptin Receptor Sales Market Share Forecast by Country (2027-2032) Table 135. Latin America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Latin America Nociceptin Receptor Market Size by Country (2021-2026) & (US$ Million) Table 137. Latin America Nociceptin Receptor Market Share by Country (2021-2026) Table 138. Latin America Nociceptin Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Latin America Nociceptin Receptor Market Share Forecast by Country (2027-2032) Table 140. Middle East and Africa Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 141. Middle East and Africa Nociceptin Receptor Sales by Country (2021-2026) & (k units) Table 142. Middle East and Africa Nociceptin Receptor Sales Market Share by Country (2021-2026) Table 143. Middle East and Africa Nociceptin Receptor Sales Forecast by Country (2027-2032) & (k units) Table 144. Middle East and Africa Nociceptin Receptor Sales Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Nociceptin Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Nociceptin Receptor Market Size by Country (2021-2026) & (US$ Million) Table 147. Middle East and Africa Nociceptin Receptor Market Share by Country (2021-2026) Table 148. Middle East and Africa Nociceptin Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Middle East and Africa Nociceptin Receptor Market Share Forecast by Country (2027-2032) Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Nociceptin Receptor Distributors List Table 153. Nociceptin Receptor Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Nociceptin Receptor Image Figure 2. Global Nociceptin Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nociceptin Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Nociceptin Receptor Sales (2021-2032) & (k units) Figure 5. GRTTA-2210 Image Figure 6. Global GRTTA-2210 Sales YoY Growth (2021-2032) & (k units) Figure 7. GRT-6010 Image Figure 8. Global GRT-6010 Sales YoY Growth (2021-2032) & (k units) Figure 9. Cebranopadol Image Figure 10. Global Cebranopadol Sales YoY Growth (2021-2032) & (k units) Figure 11. BTRX-246040 Image Figure 12. Global BTRX-246040 Sales YoY Growth (2021-2032) & (k units) Figure 13. AT-403 Image Figure 14. Global AT-403 Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Nociceptin Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Nociceptin Receptor Market Share by Type 2025 VS 2032 Figure 19. North America Nociceptin Receptor Sales Market Share in Volume by Type in 2025 Figure 20. North America Nociceptin Receptor Sales Market Share in Value by Type in 2025 Figure 21. Europe Nociceptin Receptor Sales Market Share in Volume by Type in 2025 Figure 22. Europe Nociceptin Receptor Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Nociceptin Receptor Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Nociceptin Receptor Sales Market Share in Value by Type in 2025 Figure 25. Latin America Nociceptin Receptor Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Nociceptin Receptor Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Nociceptin Receptor Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Nociceptin Receptor Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Nociceptin Receptor Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Major Depressive Disorder Image Figure 32. Global Major Depressive Disorder Sales YoY Growth (2021-2032) & (k units) Figure 33. Drug Addiction Image Figure 34. Global Drug Addiction Sales YoY Growth (2021-2032) & (k units) Figure 35. Diabetic Neuropathic Pain Image Figure 36. Global Diabetic Neuropathic Pain Sales YoY Growth (2021-2032) & (k units) Figure 37. Postherpetic Neuralgia Image Figure 38. Global Postherpetic Neuralgia Sales YoY Growth (2021-2032) & (k units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 41. Global Nociceptin Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Nociceptin Receptor Market Share by Application 2025 VS 2032 Figure 43. North America Nociceptin Receptor Sales Market Share in Volume by Application in 2025 Figure 44. North America Nociceptin Receptor Sales Market Share in Value by Application in 2025 Figure 45. Europe Nociceptin Receptor Sales Market Share in Volume by Application in 2025 Figure 46. Europe Nociceptin Receptor Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Nociceptin Receptor Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Nociceptin Receptor Sales Market Share in Value by Application in 2025 Figure 49. Latin America Nociceptin Receptor Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Nociceptin Receptor Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Nociceptin Receptor Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Nociceptin Receptor Sales Market Share in Value by Application in 2025 Figure 53. North America Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America Nociceptin Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Nociceptin Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe Nociceptin Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Nociceptin Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific Nociceptin Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Nociceptin Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America Nociceptin Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Nociceptin Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Nociceptin Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa Nociceptin Receptor Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Nociceptin Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Nociceptin Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Nociceptin Receptor Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Nociceptin Receptor Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • GRTTA-2210
  • GRT-6010
  • Cebranopadol
  • BTRX-246040
  • AT-403
  • Others
Applications
  • Major Depressive Disorder
  • Drug Addiction
  • Diabetic Neuropathic Pain
  • Postherpetic Neuralgia
  • Others
Companies covered
  • Serodus ASA
  • Orexigen Therapeutics Inc
  • Grunenthal GmbH
  • Fuso Pharmaceutical Industries Ltd
  • Blackthorn Therapeutics Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nociceptin Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nociceptin Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nociceptin Receptor Market by Type
  6. 1.3.1 GRTTA-2210
  7. 1.3.2 GRT-6010
  8. 1.3.3 Cebranopadol
  9. 1.3.4 BTRX-246040
  10. 1.3.5 AT-403
  11. 1.3.6 Others
  12. 1.4 Global Nociceptin Receptor Market Size by Type
  13. 1.4.1 Global Nociceptin Receptor Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Nociceptin Receptor Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Nociceptin Receptor Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Nociceptin Receptor Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Nociceptin Receptor Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Nociceptin Receptor Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Nociceptin Receptor Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Nociceptin Receptor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nociceptin Receptor Industry Trends
  2. 2.2 Nociceptin Receptor Industry Drivers
  3. 2.3 Nociceptin Receptor Industry Opportunities and Challenges
  4. 2.4 Nociceptin Receptor Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nociceptin Receptor Revenue (2021-2026)
  2. 3.2 Global Top Players by Nociceptin Receptor Sales (2021-2026)
  3. 3.3 Global Top Players by Nociceptin Receptor Price (2021-2026)
  4. 3.4 Global Nociceptin Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nociceptin Receptor Major Company Production Sites & Headquarters
  6. 3.6 Global Nociceptin Receptor Company, Product Type & Application
  7. 3.7 Global Nociceptin Receptor Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nociceptin Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nociceptin Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nociceptin Receptor Tier 1, Tier 2, and Tier 3
4 Nociceptin Receptor Regional Status and Outlook
  1. 4.1 Global Nociceptin Receptor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nociceptin Receptor Historic Market Size by Region
  3. 4.2.1 Global Nociceptin Receptor Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nociceptin Receptor Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nociceptin Receptor Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nociceptin Receptor Forecasted Market Size by Region
  7. 4.3.1 Global Nociceptin Receptor Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nociceptin Receptor Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nociceptin Receptor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nociceptin Receptor by Application
  1. 5.1 Nociceptin Receptor Market by Application
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Drug Addiction
  4. 5.1.3 Diabetic Neuropathic Pain
  5. 5.1.4 Postherpetic Neuralgia
  6. 5.1.5 Others
  7. 5.2 Global Nociceptin Receptor Market Size by Application
  8. 5.2.1 Global Nociceptin Receptor Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Nociceptin Receptor Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Nociceptin Receptor Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Nociceptin Receptor Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Nociceptin Receptor Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Nociceptin Receptor Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Nociceptin Receptor Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Nociceptin Receptor Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Serodus ASA
  2. 6.1.1 Serodus ASA Company Information
  3. 6.1.2 Serodus ASA Business Overview
  4. 6.1.3 Serodus ASA Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Serodus ASA Nociceptin Receptor Product Portfolio
  6. 6.1.5 Serodus ASA Recent Developments
  7. 6.2 Orexigen Therapeutics Inc
  8. 6.2.1 Orexigen Therapeutics Inc Company Information
  9. 6.2.2 Orexigen Therapeutics Inc Business Overview
  10. 6.2.3 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Orexigen Therapeutics Inc Nociceptin Receptor Product Portfolio
  12. 6.2.5 Orexigen Therapeutics Inc Recent Developments
  13. 6.3 Grunenthal GmbH
  14. 6.3.1 Grunenthal GmbH Company Information
  15. 6.3.2 Grunenthal GmbH Business Overview
  16. 6.3.3 Grunenthal GmbH Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grunenthal GmbH Nociceptin Receptor Product Portfolio
  18. 6.3.5 Grunenthal GmbH Recent Developments
  19. 6.4 Fuso Pharmaceutical Industries Ltd
  20. 6.4.1 Fuso Pharmaceutical Industries Ltd Company Information
  21. 6.4.2 Fuso Pharmaceutical Industries Ltd Business Overview
  22. 6.4.3 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product Portfolio
  24. 6.4.5 Fuso Pharmaceutical Industries Ltd Recent Developments
  25. 6.5 Blackthorn Therapeutics Inc
  26. 6.5.1 Blackthorn Therapeutics Inc Company Information
  27. 6.5.2 Blackthorn Therapeutics Inc Business Overview
  28. 6.5.3 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Blackthorn Therapeutics Inc Nociceptin Receptor Product Portfolio
  30. 6.5.5 Blackthorn Therapeutics Inc Recent Developments
7 North America by Country
  1. 7.1 North America Nociceptin Receptor Sales by Country
  2. 7.1.1 North America Nociceptin Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nociceptin Receptor Sales by Country (2021-2026)
  4. 7.1.3 North America Nociceptin Receptor Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nociceptin Receptor Market Size by Country
  6. 7.2.1 North America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nociceptin Receptor Market Size by Country (2021-2026)
  8. 7.2.3 North America Nociceptin Receptor Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nociceptin Receptor Sales by Country
  2. 8.1.1 Europe Nociceptin Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nociceptin Receptor Sales by Country (2021-2026)
  4. 8.1.3 Europe Nociceptin Receptor Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nociceptin Receptor Market Size by Country
  6. 8.2.1 Europe Nociceptin Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nociceptin Receptor Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nociceptin Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nociceptin Receptor Sales by Country
  2. 9.1.1 Asia-Pacific Nociceptin Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nociceptin Receptor Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nociceptin Receptor Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nociceptin Receptor Market Size by Country
  6. 9.2.1 Asia-Pacific Nociceptin Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nociceptin Receptor Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nociceptin Receptor Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nociceptin Receptor Sales by Country
  2. 10.1.1 South America Nociceptin Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nociceptin Receptor Sales by Country (2021-2026)
  4. 10.1.3 South America Nociceptin Receptor Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nociceptin Receptor Market Size by Country
  6. 10.2.1 South America Nociceptin Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nociceptin Receptor Market Size by Country (2021-2026)
  8. 10.2.3 South America Nociceptin Receptor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nociceptin Receptor Sales by Country
  2. 11.1.1 Middle East and Africa Nociceptin Receptor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nociceptin Receptor Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nociceptin Receptor Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nociceptin Receptor Market Size by Country
  6. 11.2.1 Middle East and Africa Nociceptin Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nociceptin Receptor Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nociceptin Receptor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nociceptin Receptor Value Chain Analysis
  2. 12.1.1 Nociceptin Receptor Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nociceptin Receptor Production Mode & Process
  7. 12.2 Nociceptin Receptor Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nociceptin Receptor Distributors
  10. 12.2.3 Nociceptin Receptor Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.